X4 Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 09, 2023 at 08:08 am EST
X4 Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 2.31 million compared to USD 21.59 million a year ago. Basic loss per share from continuing operations was USD 0.01.
For the nine months, net loss was USD 82.04 million compared to USD 64.76 million a year ago. Basic loss per share from continuing operations was USD 0.48.